European Association of Urology Section of Urolithiasis and International Alliance of Urolithiasis Joint Consensus on Retrograde Intrarenal Surgery for the Management of Renal Stones.


Journal

European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661

Informations de publication

Date de publication:
09 2022
Historique:
received: 05 08 2021
revised: 01 10 2021
accepted: 20 10 2021
pubmed: 28 11 2021
medline: 6 12 2022
entrez: 27 11 2021
Statut: ppublish

Résumé

Retrograde intrarenal surgery (RIRS) has become the preferred treatment modality for nephrolithiasis. However, because of ongoing uncertainties regarding the optimal perioperative management, operative technique, and postoperative follow-up, as well as a lack of standardization for outcome reporting, consensus is needed to achieve more uniform clinical practice worldwide. To develop recommendations for RIRS on the basis of existing data and expert consensus. A protocol-driven, three-phase study was conducted by the European Association of Urology Section of Urolithiasis (EULIS) and the International Alliance of Urolithiasis (IAU). The process included: (1) a nonsystematic review of the literature to define domains for discussion; (2) a two-round modified Delphi survey involving experts in this field; and (3) an additional group meeting and third-round survey involving 64 senior representative members to formulate the final conclusions. The results from each previous round were returned to the participants for re-evaluation of their decisions during the next round. The agreement threshold was set at 70%. The panel included 209 participants who developed 29 consensus statements on the following topics of interest: (1) perioperative infection management; (2) perioperative antithrombotic therapy; (3) fundamentals of the operative technique; and (4) standardized outcome reporting. Although this consensus can be considered as a useful reference for more clinically oriented daily practice, we also acknowledge that a higher level of evidence from further clinical trials is needed. The consensus statements aim to guide and standardize clinical practice and research on RIRS and to recommend standardized outcome reporting. An international consensus on the best practice for minimally invasive surgery for kidney stones was organized and developed by two international societies. It is anticipated that this consensus will provide further guidance to urologists and may help to improve clinical outcomes for patients.

Sections du résumé

BACKGROUND
Retrograde intrarenal surgery (RIRS) has become the preferred treatment modality for nephrolithiasis. However, because of ongoing uncertainties regarding the optimal perioperative management, operative technique, and postoperative follow-up, as well as a lack of standardization for outcome reporting, consensus is needed to achieve more uniform clinical practice worldwide.
OBJECTIVE
To develop recommendations for RIRS on the basis of existing data and expert consensus.
DESIGN, SETTING, AND PARTICIPANTS
A protocol-driven, three-phase study was conducted by the European Association of Urology Section of Urolithiasis (EULIS) and the International Alliance of Urolithiasis (IAU). The process included: (1) a nonsystematic review of the literature to define domains for discussion; (2) a two-round modified Delphi survey involving experts in this field; and (3) an additional group meeting and third-round survey involving 64 senior representative members to formulate the final conclusions.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS
The results from each previous round were returned to the participants for re-evaluation of their decisions during the next round. The agreement threshold was set at 70%.
RESULTS AND LIMITATIONS
The panel included 209 participants who developed 29 consensus statements on the following topics of interest: (1) perioperative infection management; (2) perioperative antithrombotic therapy; (3) fundamentals of the operative technique; and (4) standardized outcome reporting. Although this consensus can be considered as a useful reference for more clinically oriented daily practice, we also acknowledge that a higher level of evidence from further clinical trials is needed.
CONCLUSIONS
The consensus statements aim to guide and standardize clinical practice and research on RIRS and to recommend standardized outcome reporting.
PATIENT SUMMARY
An international consensus on the best practice for minimally invasive surgery for kidney stones was organized and developed by two international societies. It is anticipated that this consensus will provide further guidance to urologists and may help to improve clinical outcomes for patients.

Identifiants

pubmed: 34836838
pii: S2405-4569(21)00290-X
doi: 10.1016/j.euf.2021.10.011
pii:
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1461-1468

Informations de copyright

Copyright © 2021 European Association of Urology. All rights reserved.

Auteurs

Guohua Zeng (G)

Department of Urology and Guangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. Electronic address: gzgyzgh@vip.tom.com.

Zhijian Zhao (Z)

Department of Urology and Guangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Giorgio Mazzon (G)

Department of Urology, San Bassiano Hospital, Vicenza, Italy.

Margaret Pearle (M)

Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Simon Choong (S)

Institute of Urology, University College Hospital London, London, UK.

Andreas Skolarikos (A)

Second Department of Urology, Sismanoglio General Hospital, Athens, Greece.

John Denstedt (J)

Division of Urology, Western University, London, ON, Canada.

Christian Seitz (C)

Department of Urology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.

Daniel Olvera Pasada (D)

Department of Urology, Hospital Zambrano Hellion, TecSalud, San Pedro Garza García, Mexico.

Cristian Fiori (C)

Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy.

Andrea Bosio (A)

Department of Urology, Città della Salute e della Scienza, Molinette University Hospital, Turin, Italy.

Athanasios Papatsoris (A)

Department of Urology, Sismanoglio General Hospital, Athens, Greece.

Carlos Enrique Méndez Probst (CE)

Department of Urology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

Daniel Perez Fentes (D)

Department of Urology, University Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain.

Kah Ann Git (K)

Department of Urology, Pantai Hospital, Penang, Malaysia.

Qinghui Wu (Q)

Urology Center, National University Hospital, Singapore.

Oliver Wiseman (O)

Department of Urology, Cambridge University Hospitals, Cambridge, UK.

Esteban Emiliani (E)

Department of Urology, Fundació Puigvert, Barcelona, Spain.

Yasser Farahat (Y)

Department of Urology, Sheikh Khalifa General Hospital, Umm Al Quwain, United Arab Emirates.

Mehmet Ilker Gökce (M)

Department of Urology, Ankara University School of Medicine, Ankara, Turkey.

Stilianos Giannakopoulos (S)

Department of Urology, Democritus University of Thrace, Alexandroupolis, Greece.

Ioannis Goumas Kartalas (I)

Department of Urology, Istituto Clinico Beato Matteo, Vigevano, Italy.

Bhaskar Somani (B)

Department of Urology, University Hospital Southampton, Southampton, UK.

Thomas Knoll (T)

Department of Urology, Mannheim University Hospital, Mannheim, Germany.

Jean de la Rosette (J)

Department of Urology, Medipol Mega University Hospital, Istanbul Medipol University, Istanbul, Turkey.

Jiehui Zhong (J)

Department of Urology and Guangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Marcus Vinicius Maroccolo (M)

Hospital de Base of the Federal District, Brasília, Brazil.

Lliya Saltirov (L)

Department of Urology and Nephrology, Military Medical Academy, Sofia, Bulgaria.

Ben Chew (B)

Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.

Kunjie Wang (K)

Department of Urology, West China Hospital of Sichuan University, Chengdu, China.

Sven Lahme (S)

Department of Urology, Siloah St. Trudpert Hospital, Pforzheim, Germany.

Guido Giusti (G)

Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy.

Stefania Ferretti (S)

Department of Urology, Hospital and University of Parma, Parma, Italy.

Sung Yong Cho (S)

Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

Petrisor Geavlete (P)

Department of Urology, Saint John Emergency Clinical Hospital, Bucharest, Romania.

Ramon Cansino (R)

Department of Urology, La Paz University Hospital, Madrid, Spain.

Guido M Kamphuis (GM)

Department of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Daron Smith (D)

Institute of Urology, University College Hospital London, London, UK.

Brian R Matlaga (BR)

Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Khurshid D Ghani (KD)

Department of Urology, University of Michigan, Ann Arbor, MI, USA.

Norberto Bernardo (N)

Department of Urology, Hospital de Clinicas Jose de San Martin, Buenos Aires, Argentina.

Andres D Silva (AD)

Department of Urology, Hospital del Salvador, Salvador, Chile.

Anthony C F Ng (ACF)

SH Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.

Sixing Yang (S)

Department of Urology, Renmin Hospital of Wuhan University, Wuhan, China.

Xiaofeng Gao (X)

Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai, China.

Olivier Traxer (O)

Department of Urology, Tenon Hospital, Paris, France.

Arkadiusz Miernik (A)

Department of Urology, Faculty of Medicine, University of Freiburg Medical Centre, Freiburg, Germany.

Evangelos Liatsikos (E)

Department of Urology, University Hospital of Patras, University of Patras, Patras, Greece.

Kandarp Priyakant Parikh (K)

Department of Genitourinary Surgery, Minimal Access Surgery Training Institute, Shyam Urosurgical Hospital, Ahmedabad, Gujarat, India.

Mordechai Duvdevani (M)

Department of Urology, Hadassah Hebrew University Hospital, Jerusalem, Israel.

Antonio Celia (A)

Department of Urology, San Bassiano Hospital, Bassano del Grappa, Italy.

Takahiro Yasui (T)

Department of Nephrourology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Albert Aquino (A)

Department of Urology, Jose R. Reyes Memorial Medical Center, Manila, Philippines.

Mohammad Alomar (M)

Department of Urology, King Khalid University Hospital & Research Centre, Riyadh, Saudi Arabia.

Vorapot Choonhaklai (V)

Departments of Urology and Surgery, Rajavithi Hospital, Bangkok, Thailand.

Bulent Erkurt (B)

Department of Urology, Istanbul Medipol University, Istanbul, Turkey.

Jonathan Glass (J)

Department of Urology, Guy's and St. Thomas' NHS Foundation Trust, London, UK.

Seshadri Sriprasad (S)

Department of Urology, Darent Valley Hospital, Dartford and Gravesham NHS Trust, Dartford, UK.

Palle J Osther (PJ)

Department of Urology, Lillebaelt Hospital, Vejle, Denmark.

Francis X Keeley (FX)

Bristol Urological Institute, North Bristol NHS Trust, Bristol, UK.

Glenn M Preminger (GM)

Department of Urology, Duke University Medical Center, Durham, NC, USA.

Marcos Cepeda Delgado (M)

Department of Urology, Rio Hortega University, Valladolid, Spain.

Edgar Beltran Suarez (E)

Department of Urology, Specialty Hospital La Raza, National Medical Center of the Mexican Institute of Social Security, Mexico City, Mexico.

Zhangqun Ye (Z)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Kemal Sarica (K)

Department of Urology, Biruni University, Medical School, Istanbul, Turkey. Electronic address: saricakemal@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH